期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 19, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/ijms19030876
关键词
angiotensin; angiotensin AT1 receptor; angiotensin AT2 receptor; mas receptor; mas-related-G protein coupled MrgD receptor; inflammation; microglia; vascular cognitive impairment (VCI); alzhemiers disease (AD); parkinson's disease (PD); aging
资金
- Veterans Affairs (VA) Merit Award [BX000347]
- VA Research Career Scientist Award
- National Institutes of Health (NIH) [R01NS083559, PO1HL128207, R21NS088016]
For many years, modulators of the renin angiotensin system (RAS) have been trusted by clinicians for the control of essential hypertension. It was recently demonstrated that these modulators have other pleiotropic properties independent of their hypotensive effects, such as enhancement of cognition. Within the brain, different components of the RAS have been extensively studied in the context of neuroprotection and cognition. Interestingly, a crosstalk between the RAS and other systems such as cholinergic, dopaminergic and adrenergic systems have been demonstrated. In this review, the preclinical and clinical evidence for the impact of RAS modulators on cognitive impairment of multiple etiologies will be discussed. In addition, the expression and function of different receptor subtypes within the RAS such as: Angiotensin II type I receptor (AT1R), Angiotensin II type II receptor (AT2R), Angiotensin IV receptor (AT4R), Mas receptor (MasR), and Mas-related-G protein-coupled receptor (MrgD), on different cell types within the brain will be presented. We aim to direct the attention of the scientific community to the plethora of evidence on the importance of the RAS on cognition and to the different disease conditions in which these agents can be beneficial.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据